Juan J. Grau

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Jean-Pascal H. Machiels, Robert I. Haddad, Jérôme Fayette et al. · The Lancet Oncology · 2015 · 386 citations

Neoadjuvant Therapy, Neck 1, Randomised Phase 3 +10

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

Ricardo Hitt, Juan J. Grau, Antonio López–Pousa et al. · Annals of Oncology · 2013 · 345 citations

Neck Cancer, Neoadjuvant Therapy, Radiation Therapy +11

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Ricardo Hitt, H. Cortés-Funes, Juan J. Grau et al. · Annals of Oncology · 2011 · 220 citations

Medicine, Pathology, Phase Ii Study +7

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.

Begoña Mellado, Dolors Colomer, T Castel et al. · Journal of Clinical Oncology · 1996 · 185 citations

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer

Giulia Bertino, Gregor Serša, Francesca de Terlizzi et al. · European Journal of Cancer · 2016 · 167 citations · Full text

Neck Cancer, European Research, Medicine +9